In March 2025, the company announced new options for just a direct-to-consumer supplying of its Wegovy weight loss drug. The company proven a new pharmacy, named NovoCare, which might cost shoppers $499 per month for usage of the drug, lower than fifty percent the expense of the drug by means of other pharmaceutical distribution networks.[fifty thr